Cystic Artery Preservation : an Additional Step for Safe Laparoscopic Cholecystectomy

January 4, 2026 updated by: Ahmad Ali Maklad, Suez University
Our aim is to feature additional steps for safe cholecystectomy by preserving the cystic artery.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Suez, Egypt
        • Suez University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 1-Patients with symptomatic gall bladder stones. 2-Patients with normal coagulation profile.

Exclusion Criteria:

  • 1- Patients with hepatic co-morbidity especially (cirrhosis). 2-Patients with previous upper abdominal surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: group B
The patients will be operated on for laparoscopic cholecystectomy with clipping or cauterization of cystic artery
Active Comparator: group (A)
The patients will be operated on for laparoscopic cholecystectomy with preservation of cystic artery for save cholecystectomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patients will be followed up by Abdominal ultrasound for post operative abdominal collection
Time Frame: one month
Follow up with ultrasound to evaluate if there's bleeding or not after preserving the cystic artery
one month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 12, 2025

Primary Completion (Estimated)

February 14, 2026

Study Completion (Estimated)

May 1, 2026

Study Registration Dates

First Submitted

November 17, 2025

First Submitted That Met QC Criteria

January 4, 2026

First Posted (Actual)

January 14, 2026

Study Record Updates

Last Update Posted (Actual)

January 14, 2026

Last Update Submitted That Met QC Criteria

January 4, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Calculous Cholecystitis

Clinical Trials on The patients will be operated on for laparoscopic cholecystectomy with preservation of cystic artery a

Subscribe